{"schema_version":"secwatch.filing_event.v1","accession":"0000917520-24-000066","form_type":"8-K","ticker":"IART","cik":"0000917520","company_name":"INTEGRA LIFESCIENCES HOLDINGS CORP","filed_at":"2024-05-13T23:59:59+00:00","discovered_at":"2026-05-14T18:03:22.443029+00:00","generated_at":"2026-06-02T03:06:50.813709+00:00","sec_items":["5.02","5.07","8.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.55,"calibrated_materiality_score":0.55,"confidence":"high","headline":"Integra LifeSciences plans $50M share repurchase; stockholders approve equity plan amendment adding 1.9M shares","bullets":["Board authorizes $50M share repurchase program; repurchases expected to begin Q2 2024 subject to market conditions.","Stockholders approved Plan Amendment: share reserve increased by 1.9M shares; tax withholding share recycling eliminated.","All eight director nominees elected with strong support (>93% of votes cast); PricewaterhouseCoopers ratified as auditor for FY2024.","Stockholders approved charter amendment to limit liability of certain officers as permitted by Delaware law (62.6M for, 9.3M against)."],"urls":{"canonical":"https://secwatch.observer/filing/0000917520-24-000066","json":"https://secwatch.observer/filing/0000917520-24-000066.json","markdown":"https://secwatch.observer/filing/0000917520-24-000066.md","text":"https://secwatch.observer/filing/0000917520-24-000066.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/917520/000091752024000066/0000917520-24-000066-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/917520/000091752024000066/iart-20240509.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-02T03:06:50.813709+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"1a8a12a3aa2b4ae72deae751ca3e3a69d61b4eea","claim":"INTEGRA LIFESCIENCES HOLDINGS CORP shareholders approved Advisory (non-binding) approval of executive compensation at the 2024-05-09 meeting.","evidence_excerpt":"The stockholders approved, on an advisory, non-binding basis, the compensation of the Company’s named executive officers, by the votes set forth below.","evidence_source":"SEC 8-K Item 5.07","evidence_url":"https://www.sec.gov/Archives/edgar/data/917520/000091752024000066/0000917520-24-000066-index.htm","confidence":0.9,"family_label":"Shareholder Votes","details":[{"label":"Proposal","value":"say on pay"},{"label":"Outcome","value":"passed"},{"label":"Meeting","value":"2024-05-09"}]},{"claim_id":"2847f6e3fe373660a8bbb4205f79824a1b0aff35","claim":"INTEGRA LIFESCIENCES HOLDINGS CORP shareholders approved Approval of the Plan Amendment at the 2024-05-09 meeting.","evidence_excerpt":"The stockholders approved the Plan Amendment, by the votes set forth below:","evidence_source":"SEC 8-K Item 5.07","evidence_url":"https://www.sec.gov/Archives/edgar/data/917520/000091752024000066/0000917520-24-000066-index.htm","confidence":0.9,"family_label":"Shareholder Votes","details":[{"label":"Proposal","value":"equity plan"},{"label":"Outcome","value":"passed"},{"label":"Meeting","value":"2024-05-09"}]},{"claim_id":"b164f66a381dd67bc89bc0987df6ca28320bfc1e","claim":"INTEGRA LIFESCIENCES HOLDINGS CORP shareholders approved Election of Directors at the 2024-05-09 meeting.","evidence_excerpt":"All of the nominees for director of the Board of Directors (the “Board”) of the Company were elected to serve until the Company’s 2025 Annual Meeting of Stockholders and until their respective successors are duly elected and qualified, by the votes set forth below.","evidence_source":"SEC 8-K Item 5.07","evidence_url":"https://www.sec.gov/Archives/edgar/data/917520/000091752024000066/0000917520-24-000066-index.htm","confidence":0.9,"family_label":"Shareholder Votes","details":[{"label":"Proposal","value":"director election"},{"label":"Outcome","value":"passed"},{"label":"Meeting","value":"2024-05-09"}]},{"claim_id":"f93eadd5877c99504ca314fe72da919b08637416","claim":"INTEGRA LIFESCIENCES HOLDINGS CORP shareholders approved Amendment to Amended and Restated Certificate of Incorporation to limit liability of certain officers at the 2024-05-09 meeting.","evidence_excerpt":"The stockholders approved an amendment to the Company’s Amended and Restated Certificate of Incorporation, as amended, to limit the liability of certain officers of the Company as permitted by recent amendments to the General Corporation Law of the State of Delaware, by the votes set forth below:","evidence_source":"SEC 8-K Item 5.07","evidence_url":"https://www.sec.gov/Archives/edgar/data/917520/000091752024000066/0000917520-24-000066-index.htm","confidence":0.9,"family_label":"Shareholder Votes","details":[{"label":"Proposal","value":"charter amendment"},{"label":"Outcome","value":"passed"},{"label":"Meeting","value":"2024-05-09"}]},{"claim_id":"fca881540262e4059da689a23e3f9fb655bc6382","claim":"INTEGRA LIFESCIENCES HOLDINGS CORP shareholders approved Ratification of appointment of PricewaterhouseCoopers LLP as independent registered public accounting firm for 2024 at the 2024-05-09 meeting.","evidence_excerpt":"The stockholders ratified the appointment of PricewaterhouseCoopers LLP as the Company’s independent registered public accounting firm for the 2024 fiscal year, by the votes set forth below.","evidence_source":"SEC 8-K Item 5.07","evidence_url":"https://www.sec.gov/Archives/edgar/data/917520/000091752024000066/0000917520-24-000066-index.htm","confidence":0.9,"family_label":"Shareholder Votes","details":[{"label":"Proposal","value":"auditor ratification"},{"label":"Outcome","value":"passed"},{"label":"Meeting","value":"2024-05-09"}]}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}